LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling

By LabMedica International staff writers
Posted on 13 Nov 2020
PerkinElmer, Inc.’s (Waltham, MA; USA) SARS-CoV-2 Real-time RT-PCR Assay has received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five specimens collected from individuals suspected of COVID-19 or asymptomatic individuals.

SARS-CoV-2 testing using saliva is less invasive, and reduces the risk of exposure to healthcare workers involved in sample collection and the need for frequent replacement of personal protective equipment. Labs in countries accepting CE mark now have the option to accept saliva specimens and implement sample pooling using the PerkinElmer SARS-CoV-2 Real-time RT-PCR Assay. Sample pooling using saliva specimens is a critical advancement made possible by PerkinElmer’s chemistry and stringent manufacturing systems. The PerkinElmer SARS-CoV-2 Real-time RT-PCR Assay is built on the most sensitive SARS-CoV-2 test with the lowest limitation of detection in the market, according to the FDA’s reference panel comparative data. The assay originally obtained its CE mark in the spring of 2020.

Illustration
Illustration

“To strike the right balance between keeping the world economy moving while ensuring safe practices, governments and private organizations are working tirelessly to increase the number of times individuals are tested for COVID-19,” said Masoud Toloue, Ph.D., Vice President & General Manager, Diagnostics, PerkinElmer. “We expect our newly released saliva-based collection and asymptomatic test solution will play a large role in this effort.”

Related Links:
PerkinElmer, Inc.


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Pan-Cancer Panel
TruSight Oncology 500
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay

Latest COVID-19 News

New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
13 Nov 2020  |   COVID-19

Long COVID Etiologies Found in Acute Infection Blood Samples
13 Nov 2020  |   COVID-19

Novel Device Detects COVID-19 Antibodies in Five Minutes
13 Nov 2020  |   COVID-19



PURITAN MEDICAL